Skip to content

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Atherosclerosis as a Neuroimmune and Neurovascular Disorder: Pharmacological Opportunities Beyond Lipid Lowering.

INTRODUCTION/OBJECTIVE Atherosclerosis is traditionally defined as a lipid-driven inflammatory disease of medium and large arteries, but vascular inflammation also interacts with immune, autonomic, metabolic, and brain vascular pathways. This narrative review synthesizes evidence supporting an artery-immune-brain frame...

F. Epelde · 0 citations
Review Aug 2026

Statin Therapy for Primary Prevention in Adults Aged 80 Years and Older: A Systematic Review Conducted in Accordance with PRISMA 2020.

INTRODUCTION Statins are well established for the primary prevention of cardiovascular disease (CVD) up to approximately 75 years of age; however, direct evidence in adults aged 80 years and older remains limited. Extrapolation from younger populations is uncertain because advanced age is associated with greater compet...

F. Epelde · 0 citations
Review Open access Jul 2026

The AI Hospital Formulary: A Practical Governance Framework for Prescribing, Monitoring, and Deprescribing Artificial Intelligence in Hospitals

The AI Hospital Formulary is proposed as a complementary institutional layer that converts external standards and existing governance approaches into documented portfolio decisions at the hospital level as an operational, proportional, and accountable framework for the safe, equitable, and sustainable adoption of hospi...

F. Epelde · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.